Multi-drug resistant tuberculosis (MDR-TB) is a predominantly difficult form of TB categorized by confrontation
to first line drugs like Rifampicin and Isoniazid without or with confrontation to any other anti-tuberculosis drugs.
Resistance to Rifampicin and Isoniazid, two frontline drugs that form the backbone of the short-course treatment, would
necessitate using drugs that are more toxic, costly and are administered for a long period the MDR-TB patients that fail
treatment have a higher risk of death. Drug resistance is entirely man-made and instigated by inconsistent or incorrect
treatment. Its emergence and increase is a growing problem. Drug resistance development is a considerable risk if patients
are not properly tested and treated. This study was done in the Department of Pulmonology treated pulmonary tuberculosis
patients. The diagnosis of post tubercular sequelae was based on the past history of treated pulmonary tuberculosis patients
along with clinico – radiological examination, negative sputum inspection for acid fast bacilli, and spirometry. Patients were
made to sit and spirometry was done using NDD easy on PC spirometer according to the ATS guidelinesddd |